Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
PALI	PALISADE BIO INC	United States	$5.71M	851,401	3.12%	96.88%	Net Buying	Net Selling
TSBX	TURNSTONE BIOLOGICS CORP	United States	$70.45M	23,099,335	46.24%	53.76%	Net Buying
RCKT	ROCKET PHARMACEUTICALS INC	United States	$2.06B	90,782,211	54.89%	45.11%	Net Selling	Net Selling
TYRA	TYRA BIOSCIENCES INC	United States	$911.57M	52,539,804	59.50%	40.50%	Net Buying	Net Selling
XERS	XERIS BIOPHARMA HOLDINGS INC	United States	$260.93M	148,255,663	40.42%	14.70%	Net Buying	Net Buying
NNVC	NANOVIRICIDES INC	United States	$22.26M	11,779,000	2.27%	97.73%
PRFX	PAINREFORM LTD	Israel	$1.35M	1,728,347	10.88%	0.00%
UPC	UNIVERSE PHARMACEUTICALS INC	China	$7.91M	3,645,974	0.18%	0.00%
REPL	REPLIMUNE GROUP INC	United States	$393.50M	61,387,786	67.71%	32.29%	Net Selling
TRML	TOURMALINE BIO INC	United States	$371.87M	25,646,509	43.00%	57.00%	Net Selling
XBIT	XBIOTECH INC	United States	$253.10M	30,457,531	11.32%	45.17%
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	United States	$2.61B	63,869,904	72.47%	27.53%	Net Buying	Net Selling
RZLT	REZOLUTE INC	United States	$118.48M	39,625,271	21.83%	78.17%	Net Buying	Net Buying
PMVP	PMV PHARMACEUTICALS INC	United States	$104.94M	51,443,488	62.78%	37.22%	Net Buying
ATHE	ALTERITY THERAPEUTICS LTD	Australia	$11.27M	2,802,360,380	0.00%	0.00%
SNSE	SENSEI BIOTHERAPEUTICS INC	United States	$37.87M	25,080,958	11.81%	71.96%	Net Selling	Net Selling
ATIP	ATI PHYSICAL THERAPY INC	United States	$21.76M	4,395,617	1.13%	98.87%	Net Selling	Net Selling
ZURA	ZURA BIO LTD	United States	$204.02M	43,593,678	27.09%	72.91%	Net Selling	Net Buying
ELDN	ELEDON PHARMACEUTICALS INC	United States	$57.32M	24,813,130	23.14%	76.86%
GPCR	STRUCTURE THERAPEUTICS INC	United States	$1.67B	139,863,370	30.45%	15.03%
ALVR	ALLOVIR INC	United States	$90.17M	114,869,175	14.62%	85.38%	Net Buying	Net Selling
CGTX	COGNITION THERAPEUTICS INC	United States	$77.71M	40,058,498	17.86%	60.43%	Net Buying	Net Selling
COYA	COYA THERAPEUTICS INC	United States	$120.02M	14,618,172	19.31%	14.55%	Net Buying
IMMX	IMMIX BIOPHARMA INC	United States	$57.58M	26,414,300	2.96%	31.17%	Net Buying
BCRX	BIOCRYST PHARMACEUTICALS INC	United States	$1.10B	206,377,088	83.05%	16.95%	Net Selling	Net Selling
MURA	MURAL ONCOLOGY PLC	Ireland	$63.97M	16,922,550	78.93%	2.66%
ADTX	ADITXT INC	United States	$3.45M	1,665,214	0.09%	99.91%	Net Selling
AURA	AURA BIOSCIENCES INC	United States	$362.16M	49,543,309	74.68%	17.46%	Net Buying
DSGN	DESIGN THERAPEUTICS INC	United States	$258.18M	56,495,039	42.98%	57.02%	Net Buying	Net Buying
KPTI	KARYOPHARM THERAPEUTICS INC	United States	$128.30M	117,710,263	62.41%	31.99%	Net Selling	Net Selling
LBPH	LONGBOARD PHARMACEUTICALS INC	United States	$782.27M	38,880,054	42.51%	0.08%	Net Selling
THAR	THARIMMUNE INC	United States	$4.43M	11,789,676	1.15%	37.02%	Net Buying
VBIV	VBI VACCINES INC	United States	$17.63M	28,432,275	3.92%	96.08%	Net Buying
KRMD	KORU MEDICAL SYSTEMS INC	United States	$101.60M	45,764,225	40.55%	49.24%	Net Buying	Net Buying
UBX	UNITY BIOTECHNOLOGY INC	United States	$25.68M	16,786,647	25.70%	51.51%	Net Selling	Net Selling
OBIO	ORCHESTRA BIOMED HOLDINGS INC	United States	$168.51M	35,777,412	37.09%	53.19%	Net Buying
ANTX	AN2 THERAPEUTICS INC	United States	$72.04M	29,770,375	54.22%	45.78%	Net Buying
SONN	SONNET BIOTHERAPEUTICS HOLDINGS INC	United States	$5.22M	3,069,516	1.86%	98.14%	Net Buying
IKT	INHIBIKASE THERAPEUTICS INC	United States	$8.48M	6,476,844	3.63%	84.17%
TENX	TENAX THERAPEUTICS INC	United States	$7.02M	1,958,245	7.69%	92.31%
AEZS	AETERNA ZENTARIS INC	Canada	$9.99M	1,213,969	2.91%	0.00%
VKTX	VIKING THERAPEUTICS INC	United States	$8.12B	110,268,210	69.23%	9.00%	Net Selling	Net Selling
ATPC	AGAPE ATP CORP	Malaysia	$18.86M	76,966,712	0.02%	0.00%
ACRV	ACRIVON THERAPEUTICS INC	United States	$198.53M	22,636,951	46.35%	53.65%	Net Buying	Net Buying
RLAY	RELAY THERAPEUTICS INC	United States	$852.20M	132,741,677	72.37%	27.63%	Net Selling	Net Selling
PULM	PULMATRIX INC	United States	$6.50M	3,652,285	4.28%	95.72%
ULS	UL SOLUTIONS INC	United States	N/A	200,000,000	0.00%	0.30%	Net Selling	Net Selling
TCON	TRACON PHARMACEUTICALS INC	United States	$4.39M	2,275,225	6.34%	93.66%	Net Selling
ESTA	ESTABLISHMENT LABS HOLDINGS INC	British Virgin Islands	$1.54B	27,514,756	72.19%	22.79%	Net Buying	Net Buying
ENTA	ENANTA PHARMACEUTICALS INC	United States	$267.92M	21,179,400	58.46%	41.54%	Net Selling	Net Buying
CTXR	CITIUS PHARMACEUTICALS INC	United States	$110.57M	159,094,781	16.86%	7.74%
PYXS	PYXIS ONCOLOGY INC	United States	$252.30M	58,133,375	15.13%	36.17%	Net Selling
AVTE	AEROVATE THERAPEUTICS INC	United States	$552.52M	27,862,961	66.43%	33.57%	Net Selling	Net Selling
RBOT	VICARIOUS SURGICAL INC	United States	$42.69M	147,215,560	44.13%	53.86%	Net Buying	Net Selling
CYTO	ALTAMIRA THERAPEUTICS LTD	Bermuda	$2.14M	1,477,785	0.52%	0.00%
JSPR	JASPER THERAPEUTICS INC	United States	$321.31M	15,063,896	60.15%	39.85%	Net Buying	Net Buying
PCVX	VAXCYTE INC	United States	$7.09B	108,795,188	83.78%	16.22%	Net Selling	Net Buying
VERA	VERA THERAPEUTICS INC	United States	$2.26B	54,701,217	55.23%	44.77%	Net Selling	Net Selling
MYGN	MYRIAD GENETICS INC	United States	$2.31B	90,507,981	92.31%	7.69%	Net Selling	Net Selling
NRBO	NEUROBO PHARMACEUTICALS INC	United States	$19.43M	4,906,002	0.25%	99.75%
ABVX	ABIVAX SA	France	$886.67M	62,928,818	33.79%	0.00%
GHRS	GH RESEARCH PLC	Ireland	$666.48M	52,028,145	56.89%	0.00%
NKTR	NEKTAR THERAPEUTICS	United States	$323.18M	183,624,620	64.89%	14.15%	Net Selling	Net Selling
HCAT	HEALTH CATALYST INC	United States	$378.41M	59,034,936	74.87%	25.13%	Net Selling	Net Selling
IONM	ASSURE HOLDINGS CORP	United States	$3.90M	9,000,000	1.83%	95.40%
AVNS	AVANOS MEDICAL INC	United States	$898.80M	45,903,911	95.66%	2.96%	Net Buying	Net Buying
IGC	IGC PHARMA INC	United States	$32.82M	63,734,439	3.87%	20.14%
NUVL	NUVALENT INC	United States	$4.23B	64,556,130	70.77%	29.23%	Net Selling	Net Selling
ABUS	ARBUTUS BIOPHARMA CORP	Canada	$543.51M	188,717,409	24.75%	75.25%	Net Selling
MLSS	MILESTONE SCIENTIFIC INC	United States	$51.32M	76,602,116	5.37%	57.60%	Net Buying	Net Buying
IONS	IONIS PHARMACEUTICALS INC	United States	$5.70B	145,965,374	96.31%	3.69%	Net Selling	Net Selling
TCBP	TC BIOPHARM (HOLDINGS) PLC	United Kingdom	$3.64M	63,902,641	0.12%	11.35%
BTAI	BIOXCEL THERAPEUTICS INC	United States	$78.44M	37,530,821	4.33%	95.67%	Net Selling	Net Selling
IBRX	IMMUNITYBIO INC	United States	$5.62B	691,567,961	8.28%	7.74%	Net Buying
NVCR	NOVOCURE LTD	Jersey	$1.77B	107,611,077	58.51%	41.49%	Net Buying	Net Buying
LGVN	LONGEVERON INC	United States	$3.66M	2,513,460	14.29%	85.71%	Net Buying	Net Buying
TDOC	TELADOC HEALTH INC	United States	$2.03B	169,588,171	75.52%	6.91%	Net Selling	Net Selling
PYPD	POLYPID LTD	Israel	$7.84M	1,653,559	1.27%	0.00%
TVTX	TRAVERE THERAPEUTICS INC	United States	$479.61M	76,129,018	59.72%	40.28%	Net Selling	Net Selling
DRRX	DURECT CORP	United States	$32.90M	31,035,981	8.68%	91.32%
MOR	MORPHOSYS AG	Germany	$2.71B	37,655,137	63.38%	0.00%
LIVN	LIVANOVA PLC	United Kingdom	$3.36B	54,151,745	90.86%	9.14%	Net Selling	Net Selling
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	United States	$14.53M	84,490,862	17.09%	18.38%
ATRA	ATARA BIOTHERAPEUTICS INC	United States	$63.82M	120,416,138	53.76%	11.03%	Net Buying	Net Selling
JYNT	JOINT CORP	United States	$246.17M	14,973,910	56.38%	43.62%	Net Buying
BBIO	BRIDGEBIO PHARMA INC	United States	$5.45B	187,129,260	55.86%	44.14%	Net Selling	Net Selling
GANX	GAIN THERAPEUTICS INC	United States	$40.71M	16,219,709	9.53%	2.11%	Net Buying	Net Buying
POAI	PREDICTIVE ONCOLOGY INC	United States	$6.62M	4,062,853	0.16%	99.84%	Net Selling
CDMO	AVID BIOSERVICES INC	United States	$550.37M	63,479,794	90.14%	9.03%	Net Selling	Net Selling
RDHL	REDHILL BIOPHARMA LTD	Israel	$17.51M	12,746,797,800	0.00%	0.00%
TBIO	TELESIS BIO INC	United States	$8.62M	1,682,794	24.92%	75.08%	Net Selling	Net Selling
MYO	MYOMO INC	United States	$110.36M	28,814,637	32.83%	11.51%	Net Buying	Net Buying
SEEL	SEELOS THERAPEUTICS INC	United States	$3.67M	13,680,576	3.20%	96.80%	Net Buying	Net Buying
AIH	AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LTD	China	$22.68M	143,363,884	0.47%	1.71%
FENC	FENNEC PHARMACEUTICALS INC	United States	$264.22M	27,099,908	4.18%	95.82%	Net Buying	Net Selling
DH	DEFINITIVE HEALTHCARE CORP	United States	$838.95M	157,697,413	28.67%	71.33%	Net Selling	Net Selling
EYEN	EYENOVIA INC	United States	$36.53M	47,386,349	24.06%	27.52%	Net Buying	Net Buying
BKD	BROOKDALE SENIOR LIVING INC	United States	$1.36B	193,012,561	39.29%	60.71%	Net Selling	Net Selling
RNLX	RENALYTIX PLC	United Kingdom	$30.83M	99,930,156	4.96%	17.67%	Net Buying	Net Buying
XAIR	BEYOND AIR INC	United States	$41.44M	36,039,056	26.23%	20.17%	Net Buying	Net Buying

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	680	-1.62%	-2.51%	-3.52%	-21.05%	6.42x	5.91x	+20.97%	+3.56%	-33.88%	+84.90%	Strong Buy
Diagnostics & Research	66	+5.11%	+7.27%	+4.18%	+9.23%	37.39x	4.36x	-13.51%	+6.44%	+11.47%	+3.98%	Buy
Drug Manufacturers - General	17	-0.53%	+1.82%	+3.59%	+14.38%	31.93x	6.33x	+33.48%	+8.06%	+14.18%	+12.79%	Buy
Drug Manufacturers - Specialty & Generic	90	-0.72%	-1.27%	+0.66%	-6.21%	-3.15x	2.17x	+11.81%	+3.11%	+6.07%	+34.14%	Buy
Healthcare Plans	12	+0.39%	+3.48%	+3.54%	+2.41%	25.16x	3.02x	+15.17%	+4.73%	+11.77%	+13.27%	Buy
Health Information Services	59	-1.02%	-2.32%	-6.09%	-23.97%	12.79x	3.34x	+7.06%	+2.44%	+6.04%	+33.12%	Buy
Medical Care Facilities	51	+0.10%	+3.37%	+1.26%	+10.73%	39.75x	4.47x	-95.44%	+6.74%	+14.01%	+14.51%	Buy
Medical Devices	153	-0.47%	-1.92%	-4.16%	-14.44%	29.79x	3.92x	+7.18%	+5.22%	+7.62%	+21.81%	Buy
Medical Distribution	9	+0.59%	+3.79%	-0.11%	+28.86%	26.83x	110.00x	-10.56%	+3.43%	+19.55%	+9.31%	Buy
Medical Instruments & Supplies	56	+0.54%	+1.52%	-0.53%	-8.80%	58.36x	3.57x	+11.29%	+7.72%	+10.10%	+19.62%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -38.53% over the past year, underperforming other healthcare stocks by -31 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 30.61% from Cross Country Healthcare's current stock price of $14.93.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the second best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -5.48% over the past year, overperforming other healthcare stocks by 2 percentage points.

3. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the third best healthcare stock with a Zen Score of 67, which is 42 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 12.67% over the past year, overperforming other healthcare stocks by 20 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 50.4% from Corcept Therapeutics's current stock price of $27.04.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.95%, which is 55 percentage points higher than the healthcare sector average of 2.88%.

Mei Pharma's dividend payout ratio of 44.6% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 14.08%, which is 11 percentage points higher than the healthcare sector average of 2.88%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.36%, which is 5 percentage points higher than the healthcare sector average of 2.88%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.3% in the last day, and up 0.86% over the last week. Novavax was the among the top gainers in the healthcare sector, gaining 98.66% yesterday.

Novavax shares are trading higher on continued strength. The company last week announced a co-exclusive licensing agreement with Sanofi to commercialize a COVID-19 vaccine and develop COVID-influenza combination vaccines.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -47.49% in the past year. It has underperformed other stocks in the healthcare sector by -40 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -31.41% in the past year. It has underperformed other stocks in the healthcare sector by -24 percentage points.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Semler Scientific has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Semler Scientific's stock has dropped -5.48% in the past year. It has overperformed other stocks in the healthcare sector by 2 percentage points.

Are healthcare stocks a good buy now?

48.62% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 35.12% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 26.88x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.